Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 2646Session 2025-2026

An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in quality health care accountability and protection, further providing for medical policies and clinical review criteria.

Printer's No. PN3642

See other bills
under the
same topic PRINTER'S NO. 3642 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.2646 Session of 2026 INTRODUCED BY DAVIDSON, WALLEN, KUZMA, PUGH, SANCHEZ, INGLIS AND VEROBISH, JUNE 17, 2026 REFERRED TO COMMITTEE ON INSURANCE, JUNE 17, 2026 AN ACTAmending the act of May 17, 1921 (P.L.682, No.284), entitled "An act relating to insurance; amending, revising, and consolidating the law providing for the incorporation of insurance companies, and the regulation, supervision, and protection of home and foreign insurance companies, Lloyds associations, reciprocal and inter-insurance exchanges, and fire insurance rating bureaus, and the regulation and supervision of insurance carried by such companies, associations, and exchanges, including insurance carried by the State Workmen's Insurance Fund; providing penalties; and repealing existing laws," in quality health care accountability and protection, further providing for medical policies and clinical review criteria.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 2154(b)(1) of the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, is amended by adding a subparagraph to read:Section 2154. Medical policies and clinical review criteria.* * *(b) Clinical review criteria.--(1) Clinical review criteria adopted by an insurer or MA or CHIP managed care plan shall, at the time of medical 1234567891011121314151617181920212223 policy development or review:* * *(v) Not exclude, restrict or delay coverage of a prescription drug solely on the basis that the drug was approved by the United States Food and Drug Administration pursuant to 21 U.S.C. § 356(c) (relating to expedited approval of drugs for serious or life-threatening diseases or conditions).* * *Section 2. This act shall take effect in 60 days.20260HB2646PN3642 - 2 - 12345678910

Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.